BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 17903248)

  • 1. Urodele p53 tolerates amino acid changes found in p53 variants linked to human cancer.
    Villiard E; Brinkmann H; Moiseeva O; Mallette FA; Ferbeyre G; Roy S
    BMC Evol Biol; 2007 Sep; 7():180. PubMed ID: 17903248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The axolotl limb: a model for bone development, regeneration and fracture healing.
    Hutchison C; Pilote M; Roy S
    Bone; 2007 Jan; 40(1):45-56. PubMed ID: 16920050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants.
    Inga A; Resnick MA
    Oncogene; 2001 Jun; 20(26):3409-19. PubMed ID: 11423991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P53 in blind subterranean mole rats--loss-of-function versus gain-of-function activities on newly cloned Spalax target genes.
    Avivi A; Ashur-Fabian O; Joel A; Trakhtenbrot L; Adamsky K; Goldstein I; Amariglio N; Rechavi G; Nevo E
    Oncogene; 2007 Apr; 26(17):2507-12. PubMed ID: 17043642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of p53 in hypoxia-stressed Spalax mimics human tumor mutation.
    Ashur-Fabian O; Avivi A; Trakhtenbrot L; Adamsky K; Cohen M; Kajakaro G; Joel A; Amariglio N; Nevo E; Rechavi G
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12236-41. PubMed ID: 15302922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of fibroblast growth factors 4, 8, and 10 in limbs, flanks, and blastemas of Ambystoma.
    Christensen RN; Weinstein M; Tassava RA
    Dev Dyn; 2002 Mar; 223(2):193-203. PubMed ID: 11836784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription pattern of p53-targeted DNA repair genes in the hypoxia-tolerant subterranean mole rat Spalax.
    Shams I; Malik A; Manov I; Joel A; Band M; Avivi A
    J Mol Biol; 2013 Apr; 425(7):1111-8. PubMed ID: 23318952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of MHC class I and class II cDNAs and possible immunodeficiency linked to class II expression in the Mexican axolotl.
    Tournefier A; Laurens V; Chapusot C; Ducoroy P; Padros MR; Salvadori F; Sammut B
    Immunol Rev; 1998 Dec; 166():259-77. PubMed ID: 9914918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sp1 plays a critical role in the transcriptional activation of the human cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by the p53 tumor suppressor protein.
    Koutsodontis G; Tentes I; Papakosta P; Moustakas A; Kardassis D
    J Biol Chem; 2001 Aug; 276(31):29116-25. PubMed ID: 11384995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factors in regenerating limbs of Ambystoma: cloning and semi-quantitative RT-PCR expression studies.
    Christensen RN; Weinstein M; Tassava RA
    J Exp Zool; 2001 Sep; 290(5):529-40. PubMed ID: 11555861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypermethylation of growth arrest DNA damage-inducible gene 45 beta promoter in human hepatocellular carcinoma.
    Qiu W; Zhou B; Zou H; Liu X; Chu PG; Lopez R; Shih J; Chung C; Yen Y
    Am J Pathol; 2004 Nov; 165(5):1689-99. PubMed ID: 15509538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor: beta signaling is essential for limb regeneration in axolotls.
    Lévesque M; Gatien S; Finnson K; Desmeules S; Villiard E; Pilote M; Philip A; Roy S
    PLoS One; 2007 Nov; 2(11):e1227. PubMed ID: 18043735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the chemosensitivity of head and neck cancer cells based on the diverse function of mutated-p53.
    Shinagawa Y; Kawamata H; Omotehara F; Nakashiro K; Hoque MO; Furihata T; Horiuchi H; Imai Y; Fujimori T; Fujibayashi T
    Int J Oncol; 2003 Feb; 22(2):383-9. PubMed ID: 12527938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning and expression of the axolotl proto-oncogene ski.
    Ludolph DC; Neff AW; Parker MA; Mescher AL; Smith RC; Malacinski GM
    Biochim Biophys Acta; 1995 Jan; 1260(1):102-4. PubMed ID: 7999783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The proapoptotic gene SIVA is a direct transcriptional target for the tumor suppressors p53 and E2F1.
    Fortin A; MacLaurin JG; Arbour N; Cregan SP; Kushwaha N; Callaghan SM; Park DS; Albert PR; Slack RS
    J Biol Chem; 2004 Jul; 279(27):28706-14. PubMed ID: 15105421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression patterns of Fgf-8 during development and limb regeneration of the axolotl.
    Han MJ; An JY; Kim WS
    Dev Dyn; 2001 Jan; 220(1):40-8. PubMed ID: 11146506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of human p53 at serine 46 determines promoter selection and whether apoptosis is attenuated or amplified.
    Mayo LD; Seo YR; Jackson MW; Smith ML; Rivera Guzman J; Korgaonkar CK; Donner DB
    J Biol Chem; 2005 Jul; 280(28):25953-9. PubMed ID: 15843377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter.
    Bian J; Sun Y
    Mol Cell Biol; 1997 Nov; 17(11):6330-8. PubMed ID: 9343394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human caspase-8 promoter sustains basal activity through SP1 and ETS-like transcription factors and can be up-regulated by a p53-dependent mechanism.
    Liedtke C; Groger N; Manns MP; Trautwein C
    J Biol Chem; 2003 Jul; 278(30):27593-604. PubMed ID: 12748179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of differential activation of target gene promoters by p53 hinge domain mutants with impaired apoptotic function.
    Kong XT; Gao H; Stanbridge EJ
    J Biol Chem; 2001 Aug; 276(35):32990-3000. PubMed ID: 11395510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.